NCT00730977View on ClinicalTrials.gov

A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

HealthyBronchiectasis

Interventions

DRUG

dry powder inhaled mannitol

single doses of 40 mg, 70 mg and 100 mg

Trial Locations (1)

Unknown

Royal Prince Alfred Hospital, Sydney

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Syntara

INDUSTRY